Skip to main content
spacbrain

Psyence Biomed Corp. / Psyence Biomed II

Closed (deSPAC)

Health Care · natural psilocybin-based therapeutics for palliative care

What it is
A private company in health care preparing to list via a SPAC merger. Full profile in progress.
What it’s doing now
Merging with Newcourt Acquisition Corp (NCAC) — closed (despac), announced Nov 15, 2023.
What you should know
Data is still being assembled for this company — what is shown below is everything we have verified so far.
Profile in progress — we only publish what we can verify in filings, and for this company that work isn’t finished. Identity and deal facts above are current; business detail, financials and peers will appear as the filings are parsed.

The deal it’s entering

Psyence Biomed Corp. / Psyence Biomed II is merging with Newcourt Acquisition Corp (NCAC) currently marked Closed (deSPAC).

Headline equity value—

How to read these numbers: headline vs effective valuation · what a definitive agreement commits

What exactly is being valued, and at what

Common questions

Is Psyence Biomed Corp. / Psyence Biomed II going public?

Psyence Biomed Corp. / Psyence Biomed II has an approved merger with the SPAC Newcourt Acquisition Corp (NCAC), announced Nov 15, 2023. Deal status: Closed (deSPAC).

Does Psyence Biomed Corp. / Psyence Biomed II have revenue?

The filings we've parsed don't state a usable revenue figure yet; this profile is updated as new documents land.

Educational content, not investment advice.

Other health care deals